Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Complete Revascularisation Following Acute MI
Author(s): Ahmed Gonnah , Nadhrah Darke , Liam Mullen , et al Added: 10 months ago

MI/ACS

Prevention & Chronic Conditions
Post-revascularisation de Winter Pattern
Author(s): Shairah Ridzuan Aw , Raja Ezman Raja Shariff Added: 1 month ago

Intervention

MI/ACS
EuroPCR 25: The DANAMI-3-PRIMULTI Trial
Author(s): Thomas Engstrøm Added: 8 months ago
EuroPCR 25 - 10-year outcomes from DANAMI-3-PRIMULTI show FFR-guided complete revascularisation in ST-elevation myocardial infarction (STEMI) reduces the risk of future events. We are joined by Dr Thomas Engstrøm (University of Copenhagen, Copenhagen, Denmark) to discuss 10-year outcomes from the multicenter, randomized DANAMI-3-PRIMULTI trial investigating FFR-guided complete… View more

Demographic

MI/ACS
OPTION–STEMI: Immediate Complete Revascularisation Fails to Show Non-Inferiority to Staged Approach
Added: 4 months ago Source:  Transcatheter Academy
The optimal timing for complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains a topic of clinical debate.¹˒² The OPTION–STEMI trial aimed to determine whether an immediate complete revascularisation strategy was non-inferior to a staged approach performed during the same index hospital admission.¹OPTION–STEMI… View more

Guidelines & Statements

Intervention
TCT 23: IFR SWEDEHEART
Author(s): Matthias Götberg Added: 2 years ago
TCT 23 - We are joined by Dr Matthias Götberg (Lund University, SE) to discuss recent findings from a study of the SWEDEHEART Registry, where the long-term outcomes of iFR vs FFR guided coronary revascularization were compared. Results suggest that in a national registry analysis of 42887 patients investigated with iFR or FFR with 5-year follow-up, similar outcomes were observed in MACE, all… View more

Intervention

Prevention & Chronic Conditions
CREST-2: Stenting Benefits in Asymptomatic Carotid Stenosis
Added: 2 days ago Source:  Radcliffe Vascular
The optimal management for patients with high-grade asymptomatic carotid stenosis remains a key clinical question, particularly with advancements in medical therapy and revascularisation techniques. The CREST-2 trials were designed to assess whether adding revascularisation to intensive medical management provides a greater benefit than intensive medical management alone in this patient… View more

Guidelines & Statements

Intervention
Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?
Author(s): Armin Arbab-Zadeh , Michelle Graham , Hector M Garcia-Garcia , et al Added: 4 months ago

Intervention

Prevention & Chronic Conditions
Complete Revascularization in Shock with Dr Tara Jones
Author(s): Tara Jones Added: 3 months ago
Learn about revascularisation strategies in cardiogenic shock after acute MI, including culprit-only vs multivessel PCI, from Dr Tara Jones (University of Utah, US).This three-part video lecture series, part of Women As One’s CLIMB® 2025 Skills Training Programme, offers case-based insights into Coronary and Mechanical Support for Cardiogenic Shock, curated by Dr Alison Duncan and Dr Frederick… View more

Heart Failure

Intervention
ESC 24: The EARTH-STEMI Meta-Analysis
Author(s): Gianluca Campo Added: 1 year ago
ESC Congress 2024 — Complete revascularisation is safe, reduces ischemic events for up to 4 years, and does not affect long-term mortality.We are joined onsite by Dr Gianluca Campo (University of Ferrara, Ferrara, IT) to discuss the findings from EARTH-STEMI. Previous RCTs have supported the benefit of complete revascularisation in the overall population, however, this has not been confirmed in… View more

Intervention
LINC 2025: 12-Month Amputation and Readmission Rates from TRUE-PTX
Author(s): Marianne Brodmann Added: 11 months ago
LINC 2025 - 12-month amputation and readmission rates from the TRUE-PTX study suggests endovascular revascularisation for peripheral artery disease (PAD) with drug-eluting devices lead to better outcomes than with bare device therapies.Dr Marianne Brodmann (Medical University of Graz, AT) joins us to discuss the TRUE-PTX study evaluating a database of patients in the US with PAD who have recieved… View more

Intervention

Vascular Disease and Surgery